Statement of Principles concerning Hodgkin's Lymphoma No. 28 of 2004

Administered by Department of Veterans' Affairs

Legislation au F2006B00110 Not in force Legislative Instrument

Legislation content

Instrument No. 28 of 2004

 

Revocation

of

Statement of Principles

concerning

 

HODGKIN’S DISEASE

 

and

 

Determination

of

Statement of Principles

concerning

 

HODGKIN’S LYMPHOMA

 

 

Veterans’ Entitlements Act 1986

and

Military Rehabilitation and Compensation Act 2004

 

1. The Repatriation Medical Authority under subsection 196B(2) and (8) of the Veterans’ Entitlements Act 1986 (the VEA):

 

(a) revokes Instrument No. 25 of 2000; and

 

(b) determines in its place the following Statement of Principles.

 

Kind of injury, disease or death

2. (a) This Statement of Principles is about Hodgkin’s lymphoma and death from Hodgkin’s lymphoma.


(b)              For the purposes of this Statement of Principles, “Hodgkin’s lymphoma”, also known as Hodgkin’s disease or Hodgkin lymphoma, means a monoclonal lymphoid neoplasm characterised by the presence of mononuclear Hodgkin cells and multinucleated Reed-Sternberg cells, or lymphocytic and histiocytic Reed-Sternberg cell variants.

(c)               Hodgkin’s lymphoma attracts ICD-10-AM code C81.

(d)              In the application of this Statement of Principles, the definition of Hodgkin’s lymphoma” is that given at paragraph 2(b) above.

 

Basis for determining the factors

3. The Repatriation Medical Authority is of the view that there is sound medical-scientific evidence that indicates that Hodgkin’s lymphoma and death from Hodgkin’s lymphoma can be related to relevant service rendered by veterans, members of Peacekeeping Forces, or members of the Forces under the VEA, or members under the Military Rehabilitation and Compensation Act 2004 (the MRCA).

 

Factors that must be related to service

4. Subject to clause 6, at least one of the factors set out in clause 5 must be related to the relevant service rendered by the person.

 

Factors

5. The factor that must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting Hodgkin’s lymphoma or death from Hodgkin’s lymphoma with the circumstances of a person’s relevant service is:

 

(a)               being infected with human immunodeficiency virus (HIV) before the clinical onset of Hodgkin’s lymphoma; or

 

(b) inhaling or absorbing a chemical agent contaminated by 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD) for a cumulative period of at least thirty days, at least five years before the clinical onset of Hodgkin’s lymphoma; or

 

(c) being:

 (i)               on land in Vietnam, or

                          (ii)  at sea in Vietnamese waters, or

                        (iii)  on board a vessel and consuming potable water supplied on that vessel, when the water supply had been produced by evaporative distillation of estuarine Vietnamese waters,

 for a cumulative period of at least thirty days, at least five years before the clinical onset of Hodgkin’s lymphoma; or

 

(d) being infected with Epstein-Barr virus before the clinical onset of Hodgkin’s lymphoma; or

 

(e)              smoking at least ten pack years of cigarettes, or the equivalent thereof in other tobacco products, before the clinical onset of Hodgkin’s lymphoma, and where smoking has ceased, the clinical onset has occurred within fifteen years of cessation; or

 

(f)               having rheumatoid arthritis at the time of the clinical onset of Hodgkin’s lymphoma; or

 

(g)              undergoing solid organ or bone marrow transplantation before the clinical onset of Hodgkin’s lymphoma; or

 

(h)              inability to obtain appropriate clinical management for Hodgkin’s lymphoma.

 

Factors that apply only to material contribution or aggravation

6. Paragraph 5(h) applies only to material contribution to, or aggravation of, Hodgkin’s lymphoma where the person’s Hodgkin’s lymphoma was suffered or contracted before or during (but not arising out of) the person’s relevant service.

 

Inclusion of Statements of Principles

7. In this Statement of Principles if a relevant factor applies and that factor includes an injury or disease in respect of which there is a Statement of Principles then the factors in that last mentioned Statement of Principles apply in accordance with the terms of that Statement of Principles.

 

Other definitions

8.                  For the purposes of this Statement of Principles:

 

“being infected with Epstein-Barr virus” means serological evidence of infection with Epstein-Barr virus;

 

“being infected with human immunodeficiency virus (HIV)” means serological evidence of infection with human immunodeficiency virus;


“being:

(i)                on land in Vietnam, or

(ii)   at sea in Vietnamese waters,” means service in at least one of the areas and at the times described in Items 4 and 8 of Schedule 2 of the VEA;

 

“death from Hodgkin’s lymphoma” in relation to a person includes death from a terminal event or condition that was contributed to by the person’s Hodgkin’s lymphoma;

 

“estuarine Vietnamese waters” means at least one of the waterways or harbours in the relevant areas described in Items 4 and 8 of Schedule 2 of the VEA;

 

“ICD-10-AM code” means a number assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, 10th revision, Australian Modification (ICD-10-AM), Fourth Edition, effective date of 1 July 2004, copyrighted by the National Centre for Classification in Health, Sydney, NSW, and having ISBN 1 86487 594 1;

 

“inhaling or absorbing a chemical agent” means:

(a)              undertaking work involving decanting or spraying,

(b)              undertaking work involving cleaning and maintenance of equipment used to apply,

(c)              having been sprayed with,

(d)              undertaking work involving the handling or sawing of timber treated with, or

(e)              working in an environment shrouded in dust from timber treated with,

one of the following chemicals

  • 2,4,5-trichlorophenoxyacetic acid,
  • 2,4,5-trichlorophenoxypropionic acid,
  • 2,4,5-trichlorophenol,
  • 2-(2,4,5-trichlorophenoxy)-ethyl 2,2-dichloropropionate,
  • o,o-dimethyl-o-(2,4,5-trichlorophenyl)-phosphorothioate,
  • pentachlorophenol,
  • 2,3,4,6-tetrachlorophenol,
  • 2,4,6-trichlorophenol,
  • 1,3,4-trichloro-2-(4-nitrophenoxy)benzene,
  • 2,4-dichloro-1-(4-nitrophenoxy)benzene, or
  • 2,4-dichloro-1-(3-methoxy-4-nitrophenoxy)-benzene;

 


“pack years of cigarettes, or the equivalent thereof in other tobacco products” means a calculation of consumption where one pack year of cigarettes equals twenty tailor made cigarettes per day for a period of one calendar year, or 7300 cigarettes. One tailor made cigarette approximates one gram of tobacco or one gram of cigar or pipe tobacco by weight. One pack year of tailor made cigarettes equates to 7300 cigarettes, or 7.3kg of smoking tobacco by weight. Tobacco products means either cigarettes, pipe tobacco or cigars smoked, alone or in any combination;

 

“potable water” means water used for drinking water, food preparation and beverage production;

 

“relevant service” means:

(a) operational service under the VEA; or

(b) peacekeeping service under the VEA; or

(c)               hazardous service under the VEA; or

(d)              warlike service under the MRCA; or

(e)               non-warlike service under the MRCA;

 

“terminal event” means the proximate or ultimate cause of death and includes:

(a) pneumonia;

(b) respiratory failure;

(c) cardiac arrest;

(d) circulatory failure; or

(e) cessation of brain function.

 

Application

9. This Instrument applies to all matters to which section 120A of the VEA or section 338 of the MRCA applies.

 

Dated this seventh day of  October  2004

 

 

The Common Seal of the    )

Repatriation Medical Authority   )

was affixed to this instrument  )

in the presence of:    )

 

KEN DONALD

CHAIRMAN

Overview

The Repatriation Medical Authority, under the authority vested in it by the Veterans’ Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004, has issued a legislative instrument to address the medical-scientific evidence linking Hodgkin’s lymphoma, also known as Hodgkin’s disease or Hodgkin lymphoma, to the service rendered by veterans, members of Peacekeeping Forces, or members of the Forces. This legislative instrument revokes the previous Statement of Principles concerning Hodgkin’s disease and replaces it with a new Statement of Principles concerning Hodgkin’s lymphoma. The objective is to ensure that veterans and eligible individuals can receive appropriate recognition and compensation for Hodgkin’s lymphoma and related deaths when there is a connection to their service. This new framework provides specific criteria, such as exposure to certain chemical agents or infection with certain viruses, that must be met to establish a link between the disease and service.

Scope and Application

The Revocation of Statement of Principles concerning Hodgkin’s Disease and Determination of Statement of Principles concerning Hodgkin’s Lymphoma legislative instrument, effective under the Veterans’ Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004, applies to all matters within the scope of section 120A of the VEA and section 338 of the MRCA. This instrument pertains to veterans, members of Peacekeeping Forces, and members of the Forces under the VEA, as well as members under the MRCA, and specifically addresses Hodgkin’s lymphoma and death from Hodgkin’s lymphoma. The legislative instrument revokes the previous Instrument No. 25 of 2000 and establishes a new Statement of Principles. It sets out specific factors that must be related to the relevant service rendered by the person, such as infection with HIV or exposure to certain chemical agents, and defines the geographic and temporal scope of relevant service. The application of this instrument is restricted to instances where there is a sound medical-scientific basis indicating a connection between Hodgkin’s lymphoma or death from Hodgkin’s lymphoma and the person’s service, with certain factors only applying to material contribution or aggravation of the condition.

Key Provisions

The legislative instrument under discussion focuses on the revocation of a prior Statement of Principles concerning Hodgkin’s disease and the establishment of a new Statement of Principles concerning Hodgkin’s lymphoma. According to section 1, the Repatriation Medical Authority (RMA) revokes Instrument No. 25 of 2000 and determines a new Statement of Principles regarding Hodgkin’s lymphoma and death from Hodgkin’s lymphoma. The key provision in section 2 clarifies that this Statement of Principles specifically addresses Hodgkin’s lymphoma, also known as Hodgkin’s disease or Hodgkin lymphoma, which is a type of cancer characterised by certain cells. Section 3 indicates that the RMA has established this new Statement of Principles based on sound medical-scientific evidence that Hodgkin’s lymphoma can be related to service rendered by veterans and other relevant personnel. Section 4 stipulates that at least one of the factors outlined in section 5 must be related to the person's relevant service for a reasonable hypothesis to be raised connecting Hodgkin’s lymphoma with their service. The factors listed in section 5 include being infected with HIV, inhaling a chemical agent contaminated by TCDD, being in Vietnam or Vietnamese waters, being infected with Epstein-Barr virus, smoking a certain amount of cigarettes, having rheumatoid arthritis, undergoing solid organ or bone marrow transplantation, or being unable to obtain appropriate clinical management for Hodgkin’s lymphoma. Section 6 specifies that the factor in section 5(h) applies only to material contribution to, or aggravation of, Hodgkin’s lymphoma if the condition was suffered or contracted before or during service. Furthermore, section 7 states that if a relevant factor includes an injury or disease with an existing Statement of Principles, the factors in that Statement also apply. Definitions provided in section 8 clarify terms such as "being infected with Epstein-Barr virus," "relevant service," and "pack years of cigarettes," among others. The application of this instrument, as detailed in section 9, extends to all matters governed by section 120A of the Veterans’ Entitlements Act 1986 (VEA) or section 338 of the Military Rehabilitation and Compensation Act 2004 (MRCA). Regarding obligations, the RMA must ensure that the new Statement of Principles accurately reflects the latest medical-scientific evidence and that all relevant factors are clearly and comprehensively outlined. The obligations extend to ensuring that veterans and other relevant personnel who may be affected by Hodgkin’s lymphoma can access the necessary information and support. Any failure to comply with these obligations could result in legal challenges or administrative reviews, potentially impacting the validity of the instrument. As for penalties and consequences, the legislative instrument itself does not explicitly state penalties for non-compliance. However, breaches of the obligations under the VEA or MRCA could lead to civil or criminal penalties as stipulated by those Acts. For example, under the VEA, penalties for non-compliance can include fines and imprisonment, while the MRCA may impose civil penalties for breaches. The severity of these penalties would depend on the nature and extent of the breach, and the specific provisions of the VEA and MRCA would apply accordingly.

Legal classification tags

Area of Law
Veterans' Law
Instrument
Legislative Instrument
Concepts
Definitions & Interpretation
Reporting & Disclosure Obligations
Regulatory Standards

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.